These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10708482)

  • 21. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
    Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM
    Biochem Biophys Res Commun; 1998 Jun; 247(3):644-53. PubMed ID: 9647747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice.
    Bol DK; Kiguchi K; Gimenez-Conti I; Rupp T; DiGiovanni J
    Oncogene; 1997 Apr; 14(14):1725-34. PubMed ID: 9135074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
    Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
    Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
    Dlugosz AA; Hansen L; Cheng C; Alexander N; Denning MF; Threadgill DW; Magnuson T; Coffey RJ; Yuspa SH
    Cancer Res; 1997 Aug; 57(15):3180-8. PubMed ID: 9242447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.
    Darwiche N; Scita G; Jones C; Rutberg S; Greenwald E; Tennenbaum T; Collins SJ; De Luca LM; Yuspa SH
    Cancer Res; 1996 Nov; 56(21):4942-9. PubMed ID: 8895748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes.
    Ando K; Saitoh A; Hino O; Takahashi R; Kimura M; Katsuki M
    Cancer Res; 1992 Feb; 52(4):978-82. PubMed ID: 1737360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
    Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
    Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
    Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
    Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization.
    Agarwal R; Mohan RR; Ahmad N; Mukhtar H
    Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
    Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK
    Cancer Res; 2000 Feb; 60(3):595-602. PubMed ID: 10676642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis.
    Ise K; Nakamura K; Nakao K; Shimizu S; Harada H; Ichise T; Miyoshi J; Gondo Y; Ishikawa T; Aiba A; Katsuki M
    Oncogene; 2000 Jun; 19(26):2951-6. PubMed ID: 10871846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene.
    Greenhalgh DA; Rothnagel JA; Quintanilla MI; Orengo CC; Gagne TA; Bundman DS; Longley MA; Roop DR
    Mol Carcinog; 1993; 7(2):99-110. PubMed ID: 7681293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas.
    Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y
    Cancer Res; 2007 Oct; 67(19):9158-68. PubMed ID: 17909021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
    Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
    Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
    Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
    Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.